An et al., 2015 - Google Patents
An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patientsAn et al., 2015
View PDF- Document ID
- 17819463278963075984
- Author
- An Y
- Cho H
- Kim T
- Keam B
- Kim J
- Wen H
- Park C
- Lee S
- Im S
- Kim J
- Choi S
- Park S
- Publication year
- Publication venue
- International journal of cancer
External Links
Snippet
Leptomeningeal carcinomatosis (LC) is a metastatic cancer invading the central nervous system (CNS). We previously reported a metabolomic diagnostic approach as tested on an animal model and compared with current modalities. Here, we provide a proof of concept by …
- 208000007650 Meningeal Carcinomatosis 0 title abstract description 94
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| An et al. | An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients | |
| Hu et al. | Radiogenomics to characterize regional genetic heterogeneity in glioblastoma | |
| Ellingson et al. | Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity | |
| Lombardi et al. | Clinical management of diffuse low-grade gliomas | |
| Fujii et al. | Diagnostic accuracy of diffusion‐weighted imaging in differentiating benign from malignant ovarian lesions | |
| Pérez-Rambla et al. | Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia | |
| Spratlin et al. | Clinical applications of metabolomics in oncology: a review | |
| Schneider et al. | Multiparametric differentiation of posterior fossa tumors in children using diffusion‐weighted imaging and short echo‐time 1H‐MR spectroscopy | |
| Piccardo et al. | Advanced MR imaging and 18 F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas | |
| Elkhaled et al. | Characterization of metabolites in infiltrating gliomas using ex vivo 1H high‐resolution magic angle spinning spectroscopy | |
| Peng et al. | Predicting isocitrate dehydrogenase (IDH) mutation status in gliomas using multiparameter MRI radiomics features | |
| Kim et al. | Role of diffusion‐weighted magnetic resonance imaging in the diagnosis of gallbladder cancer | |
| Sunwoo et al. | Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS‐MLPA in patients with glioblastoma multiforme | |
| Jenkinson et al. | Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype | |
| Oh et al. | Application of 3D fast spin-echo T1 black-blood imaging in the diagnosis and prognostic prediction of patients with leptomeningeal carcinomatosis | |
| Jiang et al. | Applications of chemical exchange saturation transfer magnetic resonance imaging in identifying genetic markers in gliomas | |
| Bennett et al. | Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours | |
| Goryawala et al. | The association between whole‐brain MR spectroscopy and IDH mutation status in gliomas | |
| Wu et al. | Pre-TACE kurtosis of ADC total derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma | |
| Wu et al. | Value of diffusion‐weighted MR imaging performed with quantitative apparent diffusion coefficient values for cervical lymphadenopathy | |
| Al-Agha et al. | Efficiency of high and standard b value diffusion‐weighted magnetic resonance imaging in grading of gliomas | |
| Li et al. | Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging | |
| Peschmann et al. | Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study | |
| Ye et al. | Diffusion histology imaging differentiates distinct pediatric brain tumor histology | |
| Prvulovic Bunovic et al. | Is elevated choline on magnetic resonance spectroscopy a reliable marker of breast lesion malignancy? |